ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
29.50
+0.46 (1.58%)
At close: Aug 21, 2026, 4:00 PM EDT
30.18
+0.68 (2.31%)
Pre-market: Aug 24, 2026, 5:50 AM EDT
ACADIA Pharmaceuticals Employees
As of December 31, 2025, ACADIA Pharmaceuticals had 798 total employees, including 796 full-time and 2 part-time employees. The number of employees increased by 144 or 22.02% compared to the previous year.
Employees
798
Change (1Y)
144
Growth (1Y)
22.02%
Revenue / Employee
$1,426,872
Profits / Employee
$476,797
Market Cap
5.08B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| CRISPR Therapeutics AG | 393 |
| Xenon Pharmaceuticals | 370 |
| Dyne Therapeutics | 289 |
| Celcuity | 155 |
| Parabilis Medicines | 145 |
| Edgewise Therapeutics | 127 |
| Definium Therapeutics | 106 |
ACAD News
- 1 hour ago - Acadia Pharmaceuticals announces EC marketing authorization for Daybu - TheFly
- 3 hours ago - European Commission Approves DAYBU® (trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms of Rett Syndrome in the European Union - Business Wire
- 6 days ago - Acadia Pharmaceuticals price target raised to $49 from $45 at UBS - TheFly
- 7 days ago - Acadia Pharmaceuticals price target raised to $41 from $38 at Needham - TheFly
- 11 days ago - ACADIA Pharmaceuticals Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 13 days ago - Acadia Pharmaceuticals price target raised to $27 from $26 at Morgan Stanley - TheFly
- 13 days ago - Acadia Pharmaceuticals price target raised to $39 from $35 at Citi - TheFly
- 18 days ago - Acadia Pharmaceuticals price target raised to $31 from $30 at BofA - TheFly